Skip to main content
LGND filings

Corporate insider profile

John L Lamattina Filing Activity

Latest reported as Corporate insider of LIGAND PHARMACEUTICALS INC (LGND).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,151,774.47
Latest transaction
Jun 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 10, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale4,591$250.88$1,151,774